← SynDRA
PROPOXYCAINE
SynDRA canonical compound SYN0004498 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | local anesthetic |
| Indication | anesthetic |
| Disease area | neurology/psychiatry |
All known targets
- SCN1A
- SCN2A
- SCN3A
- SCN10A
- SCN11A
- SCN4A
- SCN5A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- KAT2A
- SAMHD1
- TDP1
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anesthetics
- Anesthetics, Local
- Central Nervous System Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- local anesthetic
Cross-references
Synonyms
- RAVOCAINE AND NOVOCAIN W/ LEVOPHED
- RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
- propoxycaine hydrochloride
- pravocaine
- ranocaine
- ravocaine
- propoxycaine HCl
- Propoxicaina
- Propoxycaine hydrochloride
- Ravocaine hydrochloride
- Propoxycaine HCl
- Propoxycaine (hydrochloride)
- Pravocaine hydrochloride
- UNII-K490D39G46
- WIN 3459
- EINECS 208-988-7
- Propoxycaine hydrochloride [USP]
- K490D39G46
- Propoxycaine hydrochloride (USP)
- C16H26N2O3
- NCGC00016505-01
- CAS-550-83-4
- Pravocaine
- Ranocaine
- Propoxicainum
- Blockain
- Propoxycaine [INN]
- CHEBI:8496
- 4-Amino-2-propoxybenzoic acid, 2-(diethylamino)ethyl ester
- EPD1EH7F53
- Propossicaina [DCIT]
- Propossicaina
- Propoxycainum
- Propoxycainum [INN-Latin]
- Propoxicaina [INN-Spanish]
- Win 3459-2
- EINECS 201-670-9
- UNII-EPD1EH7F53
Look up PROPOXYCAINE in the interactive SynDRA portal →